[SCHEDULE 13G/A] SunLink Health Systems, Inc SEC Filing

Rhea-AI Filing Summary

The Radoff Family Foundation and Bradley L. Radoff disclosed their holdings in SunLink Health Systems (SSY). The Foundation directly owns 345,000 shares (about 4.9% of the outstanding common stock) and Mr. Radoff directly owns 344,300 shares. Combined, Mr. Radoff may be deemed to beneficially own 689,300 shares, or roughly 9.8% of the company, based on the issuer's reported outstanding share count of 7,040,603 shares.

The filing details voting and dispositive authority: sole voting/dispositive power over 344,300 shares and shared voting/dispositive power over 345,000 shares (via the Foundation). The reporting persons state the securities are not held to change or influence control of the issuer and disclaim beneficial ownership of securities they do not directly own.

Positive

• Transparent disclosure of both foundation-held and personally held shares with clear numerical breakdowns
• Material stake disclosed: aggregate 689,300 shares (~9.8%) which exceeds the 5% reporting threshold
• Voting and dispositive power detail provided (sole vs shared), improving clarity for investors
• Uses issuer-reported outstanding share base (7,040,603) to calculate percentages

Negative

• Concentration of ownership approaching 10%, which may affect market perception of influence or liquidity
• Shared voting/dispositive power between the individual and the foundation could complicate governance alignments
• No details provided on timing or manner of acquisitions (purchase dates, transactions or sources of the shares)

Insights

Financial Analyst

TL;DR: Aggregate stake near 10% is a material minority position that merits investor attention but is disclosed as non-control.

The Radoff reporting group holds an aggregate of 689,300 shares (~9.8% of 7,040,603 outstanding). That places the group above the 5% reporting threshold and identifies them as a significant minority holder. The split between 344,300 shares of sole power and 345,000 shares of shared power clarifies direct versus foundation-held influence. This disclosure is informational and does not assert any intent to effect control.

Corporate Governance Expert

TL;DR: Ownership structure mixes direct and foundation holdings, creating overlapping voting and dispositive interests that affect governance dynamics.

The filing documents shared voting and dispositive power between an individual and a related foundation, which can create concentrated influence despite no stated control intent. The reporting persons explicitly disclaim beneficial ownership of shares they do not directly own and certify the holdings are not intended to change issuer control. Investors should note the clear disclosure of voting/dispositive splits and the 7,040,603 share base used to calculate percentages.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

SUNLINK HEALTH SYSTEMS INC

(Name of Issuer)

Common Shares, without par value

(Title of Class of Securities)

86737U102

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 86737U102

1

Names of Reporting Persons

Radoff Family Foundation

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

TEXAS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 345,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 345,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

345,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.9 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. 86737U102

1

Names of Reporting Persons

Radoff Bradley Louis

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 344,300.00
6	Shared Voting Power 345,000.00
7	Sole Dispositive Power 344,300.00
8	Shared Dispositive Power 345,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

689,300.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.8 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: SUNLINK HEALTH SYSTEMS INC
(b)	Address of issuer's principal executive offices: 900 Circle 75 Parkway, Suite 690, Atlanta, Georgia 30339
Item 2.
(a)	Name of person filing: This statement is filed by The Radoff Family Foundation, a Texas non-profit corporation ("Radoff Foundation"), and Bradley L. Radoff. Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons." Mr. Radoff serves as a director of Radoff Foundation and may be deemed to beneficially own the Common Shares, without par value (the "Shares") owned directly by Radoff Foundation.
(b)	Address or principal business office or, if none, residence: The address of the principal office of each of the Reporting Persons is 2727 Kirby Drive, Unit 29L, Houston, Texas 77098.
(c)	Citizenship: Radoff Foundation is organized under the laws of the State of Texas and Mr. Radoff is a citizen of the United States of America.
(d)	Title of class of securities: Common Shares, without par value
(e)	CUSIP No.: 86737U102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: As of the close of business on June 30, 2025: (i) Radoff Foundation directly owned 345,000 Shares; and (ii) Mr. Radoff directly owned 344,300 Shares. Mr. Radoff, as a director of Radoff Foundation, may also be deemed the beneficial owner of the 345,000 Shares owned by Radoff Foundation, which, together with the 344,300 Shares he directly owned, constitutes an aggregate of 689,300 Shares beneficially owned by Mr. Radoff. The filing of this Schedule 13G shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.
(b)	Percent of class: The following percentages are based on 7,040,603 Shares outstanding as of June 20, 2025, which is the total number of Shares outstanding as disclosed in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on June 25, 2025. As of the close of business on June 30, 2025, (i) Radoff Foundation beneficially owned approximately 4.9% of the outstanding Shares and (ii) Mr. Radoff may have been deemed to beneficially own approximately 9.8% of the outstanding Shares.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Cover Pages Items 5-9.
	(ii) Shared power to vote or to direct the vote: See Cover Pages Items 5-9.
	(iii) Sole power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
	(iv) Shared power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. See Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons on February 21, 2025.
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Radoff Family Foundation

Signature:	/s/ Bradley L. Radoff
Name/Title:	Bradley L. Radoff, Director
Date:	08/13/2025

Radoff Bradley Louis

Signature:	/s/ Bradley L. Radoff
Name/Title:	Bradley L. Radoff
Date:	08/13/2025

FAQ

How many SunLink Health (SSY) shares does the Radoff Family Foundation own?

The Radoff Family Foundation directly owns 345,000 shares, representing approximately 4.9% of the outstanding common stock.

How many SSY shares does Bradley L. Radoff personally own and what is his aggregate stake?

Bradley L. Radoff directly owns 344,300 shares. Together with the foundation-held shares he may be deemed to beneficially own 689,300 shares, or about 9.8% of the company.

What voting and dispositive powers are reported for the Radoff filings?

The filing reports sole voting/dispositive power over 344,300 shares and shared voting/dispositive power over 345,000 shares.

What share count was used to calculate the ownership percentages for SSY?

Percentages are based on the issuer's reported outstanding share base of 7,040,603 shares as disclosed in the company's proxy statement.

Does the filing state that the shares are held to change control of SunLink (SSY)?

No. The reporting persons certify that the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.